Allelic and locus heterogeneity in inherited venous malformations

Human Molecular Genetics

Volumn 8, Issue 7, 1999, Pages 1279-1289

  Calvert, Jennifer T ^a   Riney, Travis J ^a   Kontos, Christopher D ^a   Cha, Eugene H ^a   Prieto, Victor G ^a   Shea, Christopher R ^a   Berg, Jonathan N ^a   Nevin, Norman C ^b   Simpson, Sheila A ^c   Pasyk, Krystyna A ^d   Speer, Marcy C ^a   Peters, Kevin G ^a   Marchuk, Douglas A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b N Ireland Regional Genetics Centre   (United Kingdom)

^c NHS GRAMPIAN   (United Kingdom)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOTRANSFERASE; PROTEIN TYROSINE KINASE;

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CELL STRAIN COS1; CHROMOSOME 9; CLINICAL ARTICLE; ENDOTHELIUM CELL; FEMALE; GENE LOCUS; GENE MAPPING; GENETIC HETEROGENEITY; GENETIC TRANSFECTION; HUMAN; MALE; MISSENSE MUTATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; VEIN MALFORMATION;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; BASE SEQUENCE; COS CELLS; FEMALE; HUMANS; LIGANDS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; PEDIGREE; PHOSPHORYLATION; SEQUENCE ALIGNMENT; TRANSFECTION; VARIATION (GENETICS); VASCULAR DISEASES;

EID: 0032770343     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/8.7.1279     Document Type: Article

References (41)

1. Flamme, I., Frolich, T. and Risau, W. (1997) Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J. Cell. Physiol., 173, 206-210.
2. Beck, L. Jr and D'Amore, P.A. (1997) Vascular development: cellular and molecular regulation. FASEB J., 11, 365-373.
3. Merenmies, J., Parada, L.F. and Henkemeyer, M. (1997) Receptor tyrosine kinase signaling in vascular development. Cell Growth Differ., 8, 3-10.
4. Gallione, C.J., Pasyk, K.A., Boon, L.M., Lennon, F., Johnson, D.W., Helmbold, E.A., Markel, D.S., Vikkula, M., Mulliken, J.B., Warman, M.L., Pericak-Vance, M.A. and Marchuk, D.A. (1995) A gene for familial venous malformations maps to chromosome 9p in a second large kindred. J. Med. Genet., 32, 197-199.
5. Mulliken, J.B. and Young, A.E. (1988) Vascular Birthmarks: Hemangiomas and Vascular Malformations. W.B. Saunders, Philadelphia, PA.
6. Pasyk, K.A., Argenta, L.C. and Erickson, R.P. (1984) Familial vascular malformations. Report of 25 members of one family. Clin. Genet., 26, 221-227.
7. Vikkula, M., Boon, L.M., Carraway, K.L.III, Calvert, J.T., Diamonti, A.J., Goumnerov, B., Pasyk, K.A., Marchuk, D.A., Warman, M.L., Cantley, L.C., Mulliken, J.B. and Olsen, B.R. (1996) Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2 [see comments]. Cell, 87, 1181-1190.
8. Boon, L.M., Mulliken, J.B., Vikkula, M., Watkins, H., Seidman, J., Olsen, B.R. and Warman, M.L. (1994) Assignment of a locus for dominantly inherited venous malformations to chromosome 9p. Hum. Mol. Genet., 3, 1583-1587.
9. Dumont, D.J., Anderson, L., Breitman, M.L. and Duncan, A.M. (1994) Assignment of the endothelial-specific protein receptor tyrosine kinase gene (TEK) to human chromosome 9p21. Genomics, 23, 512-513.
10. Dumont, D.J., Yamaguchi, T.P., Conlon, R.A., Rossant, J. and Breitman, M.L. (1992) tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. Oncogene, 7, 1471-1480.
11. Dumont, D.J., Fong, G.H., Puri, M.C., Gradwohl, G., Alitalo, K. and Breitman, M.L. (1995) Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev. Dyn., 203, 80-92.
12. Schnurch, H. and Risau, W. (1993) Expression of tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial cell lineage. Development, 119, 957-968.
13. Hashiyama, M., Iwama, A., Ohshiro, K., Kurozumi, K., Yasunaga, K., Shimizu, Y., Masuho, Y., Matsuda, I., Yamaguchi, N. and Suda, T. (1996) Predominant expression of a receptor tyrosine kinase, TIE, in hematopoietic stem cells and B cells. Blood, 87, 93-101.
14. Ziegler, S.F., Bird, T.A., Schneringer, J.A., Schooley, K.A. and Baum, P.R. (1993) Molecular cloning and characterization of a novel receptor protein tyrosine kinase from human placenta. Oncogene, 8, 663-670.
15. Korhonen, J., Partanen, J., Armstrong, E., Vaahtokari, A., Elenius, K., Jalkanen, M. and Alitalo, K. (1992) Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization. Blood, 80, 2548-2555.
16. Huang, L., Turck, C.W., Rao, P. and Peters, K.G. (1995) GRB2 and SH-PTP2: potentially important endothelial signaling molecules downstream of the TEK/TIE2 receptor tyrosine kinase. Oncogene, 11, 2097-2103.
17. Koblizek, T.I., Weiss, C., Yancopoulos, G.D., Deutsch, U. and Risau, W. (1998) Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr. Biol., 8, 529-532.
18. Davis, S., Aldrich, T.H., Jones, P.F., Acheson, A., Compton, D.L., Jain, V., Ryan, T.E., Bruno, J., Radziejewski, C., Maisonpierre, P.C. and Yancopoulos, G.D. (1996) Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning [see comments]. Cell, 87, 1161-1169.
19. Swarup, G., Cohen, S. and Garbers, D.L. (1982) Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate. Biochem. Biophys. Res. Commun., 107, 1104-1109.
20. Kontos, C.D., Stauffer, T.P., Yang, W.P., York, J.D., Huang, L., Blanar, M.A., Meyer, T. and Peters, K.G. (1998) Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphalidylinositol 3-kinase and Akt. Mol. Cell. Biol., 18, 4131-4140.
21. Jones, N. and Dumont, D.J. (1998) The Tek/Tie2 receptor signals through a novel Dok-related docking protein, Dok-R. Oncogene, 17, 1097-1108.
22. Dumont, D.J., Gradwohl, G., Fong, G.H., Puri, M.C., Gertsenstein, M., Auerbach, A. and Breitman, M.L. (1994) Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev., 8, 1897-1909.
23. Sato, T.N., Tozawa, Y., Deutsch, U., Wolburg-Buchholz, K., Fujiwara, Y., Gendron-Maguire, M., Gridley, T., Wolburg, H., Risau, W. and Qin, Y. (1995) Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature, 376, 70-74.
24. Wong, A.L., Haroon, Z.A., Werner, S., Dewhirst, M.W., Greenberg, C.S. and Peters, K.G. (1997) Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ. Res., 81, 567-574.
25. Peters, K.G., Coogan, A., Berry, D., Marks, J., Iglehart, J.D., Kontos, C.D., Rao, P., Sankar, S. and Trogan, E. (1998) Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis. Br. J. Cancer, 77, 51-56.
26. Lin, P., Polverini, P., Dewhirst, M., Shan, S., Rao, P.S. and Peters, K. (1997) Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth. J. Clin. Invest., 100, 2072-2078.
27. Lin, P., Buxton, J.A., Acheson, A., Radziejewski, C., Maisonpierre, P.C., Yancopoulos, G.D., Channon, K.M., Hale, L.P., Dewhirst, M.W., George, S.E. and Peters, K.G. (1998) Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2. Proc. Natl Acad. Sci. USA, 95, 8829-8834.
28. Chang, H.W., Aoki, M., Fruman, D., Auger, K.R., Bellacosa, A., Tsichlis, P.N., Cantley, L.C., Roberts, T.M. and Vogt, P.K. (1997) Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science, 276, 1848-1850.
29. Naski, M.C., Wang, Q., Xu, J. and Ornitz, D.M. (1996) Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nature Genet., 13, 233-237.
30. Pawson, T. (1995) Protein modules and signalling networks. Nature, 373, 573-580.
31. Folkman, J. and D'Amore, P.A. (1996) Blood vessel formation: what is its molecular basis?. Cell, 87, 1153-1155.
32. Grotendorst, G.R., Chang, T., Seppa, H.H., Kleinman, H.K. and Martin, G.R. (1982) Platelet-derived growth factor is a chemoattractant for vascular smooth muscle cells. J. Cell. Physiol., 113, 261-266.
33. Grotendorst, G.R., Seppa, H.E., Kleinman, H.K. and Martin, G.R. (1981) Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor. Proc. Natl Acad. Sci. USA, 78, 3669-3672.
34. Westermark, B., Siegbahn, A., Heldin, C.H. and Claesson-Welsh, L. (1990) B-type receptor for platelet-derived growth factor mediates a chemotactic response by means of ligand-induced activation of the receptor protein-tyrosine kinase. Proc. Natl Acad. Sci. USA, 87, 128-132.
35. Meyer, D. and Birchmeier, C. (1995) Multiple essential functions of neuregulin in development [see comments]. Nature, 378, 386-390. [Erratum: Nature, 378, 753.]
36. Korpelainen, E., Kurkkainen, M., Gunji, Y., Vikkula, M. and Alitalo, K. (1999) Endothelial receptor tyrosine kinases activate the STAT signaling pathway: mutant Tie-2 causing venous malformations signals a distinct STAT activation response. Oncogene, 18, 1-8.
37. Ulloa, L., Doody, J. and Massague, J. (1999) Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature, 397, 710-713.
38. Cheung, A.M., Stewart, R.J. and Marsden, P.A. (1998) Endothelial Tie2/ Tek ligands angiopoietin-1 (ANGPT1) and angiopoietin-2 (ANGPT2): regional localization of the human genes to 8q22.3-q23 and 8p23. Genomics, 48, 389-391.
39. McDonald, M.T., Papenberg, K.A., Ghosh, S., Glatfelter, A.A., Biesecker, B.B., Helmbold, E.A., Markel, D.S., Zolotor, A., McKinnon, W.C., Vanderstoep, J.L., Jackson, C.E., Iannuzzi, M., Collins, F.S., Boehnke, M., Porteous, M.E., Guttmacher, A.E. and Marchuk, D.A. (1994) A disease locus for hereditary haemorrhagic telangiectasia maps to chromosome 9q33-34. Nature Genet., 6, 197-204.
40. Walter, J.W., Blei, F., Anderson, J.L., Orlow, S.J., Speer, M.C. and Marchuk, D.A. (1999) Genetic mapping of a novel familial form of infantile hemangioma. Am. J Med. Genet., 82, 77-83.
41. Golemis, E.A., Gyuris, J. and Brent, R. (1998) In Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A. and Struhl, K. (eds), Current Protocols in Molecular Biology. John Wiley and Sons, pp. 13.14.1-13.14.17.